Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

National Enzyme Company

National Enzyme Company?uq=3Oe4kK1Z
1932 FOUNDED
M&A STATUS
101-200 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Manufacturer of enzyme-based dietary supplements. The company offers a range of enzyme-based nutritional supplements to improve cognitive and sleep functions, digestive health, joint & bone functions, immunity, metabolism, weight management and women's health and provides product development, blending, encapsulating, tablet packing, convenience packaging, full-service bottling, graphics, labeling and fulfillment services, enabling client to gain a one stop solution for all their contract manufacturing needs.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Food Products
Other Industries
Other Healthcare
Parent Company
Primary Office
  • 3800 Cobb International Boulevard
  • Kennesaw, GA 30152
  • United States

+1 (417) 000-0000

National Enzyme Company Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore National Enzyme Company‘s full profile, request access.

Request full access to PitchBook

National Enzyme Company Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore National Enzyme Company‘s full profile, request access.

Request full access to PitchBook

National Enzyme Company Executive Team (3)

Name Title Board
Seat
Contact
Info
Nicholas Bruns Ph.D President & Chief Executive Officer
Kim Crouse Chief Financial Officer

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »